Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Sep 24, 2026
Bitwise Solana Staking ETF (BSOL) Climbs +18% in 30 Days as Solana Rebounds

Bitwise Solana Staking ETF (BSOL) Climbs +18% in 30 Days as Solana Rebounds

Key Takeaways

  • BSOL gained roughly 18% over the last 30 days, tracking a sharp rally in Solana (SOL), the digital asset that underlies the fund.
  • Over the past quarter, the fund has advanced approximately 77%, reflecting a broad recovery in Solana from its mid-year lows.
  • Primary catalysts include protocol upgrades, favorable regulatory developments, sustained ETF inflows, rising staking demand, and a short squeeze in SOL derivatives.
  • BSOL is a single-asset fund offering 100% direct exposure to Solana, with substantially all of its holdings staked to generate additional rewards.
  • The fund carries a 0.20% expense ratio and recently surpassed $1.2 billion in assets under management (AUM), a record high.

Overview of the Bitwise Solana Staking ETF (BSOL)

The Bitwise Solana Staking ETF (BSOL) is a grantor trust that seeks to provide exposure to the value of Solana, a proof-of-stake Layer-1 blockchain. Launched in late October 2025, it was the first U.S. exchange-traded product (ETP) offering 100% direct exposure to SOL, and it trades on NYSE Arca.

Unlike diversified equity or bond funds, BSOL holds a single asset: Solana. Its portfolio is therefore not spread across sectors or dozens of companies but concentrated entirely in one digital asset. The fund's defining feature is its staking strategy. It stakes substantially all of its Solana holdings and reinvests the resulting rewards, which have historically averaged around 7% annually, back into the fund rather than distributing them to shareholders. This structure compounds yield over time while the expense ratio remains at 0.20%.

This concentrated, single-asset structure explains the fund's volatility. BSOL's price movement is essentially a direct reflection of SOL's price, amplified slightly by the compounding effect of staking rewards. When Solana rallies, BSOL tends to rally in near lockstep; when Solana sells off, the fund declines correspondingly. I also checked this using Tickeron’s AI Screener to see how the fund compares to other crypto-linked products.

Recent Price Performance: Last 30 Days and the Quarter

Over the last 30 days, BSOL climbed from approximately $13.44 to roughly $15.85, a gain of about 18%. The advance was not gradual; it was a trend-driven move punctuated by several outsized daily swings, consistent with the high volatility typical of crypto-linked products.

On a longer horizon, the performance has been even more pronounced. Roughly three months earlier, BSOL traded near $8.95, meaning the fund has appreciated approximately 77% over the past quarter. That rebound followed a pronounced drawdown in the first half of the period, when Solana weakened alongside the broader digital-asset complex. The recovery has been characterized by a sharp, momentum-fueled re-rating rather than steady, low-volatility appreciation.

Drivers Behind the 30-Day Move

Because BSOL is a pure Solana vehicle, its recent move mirrors the drivers behind SOL itself. Several forces converged during the period.

Network upgrades. Solana activated changes that shortened its target slot time from 300 milliseconds to 250 milliseconds, increasing block frequency by roughly 17%, and continued testing the Alpenglow upgrade designed to cut finality from about 12.8 seconds toward 100 to 150 milliseconds. These improvements reinforced the network's positioning as high-throughput infrastructure.

Regulatory developments. The SEC introduced an Innovation Exemption framework for tokenized U.S. equities, a development seen as favorable to Solana's role in tokenization. Even after the CLARITY Act failed in the Senate by a narrow margin, regulators published additional crypto rule packages, and SOL rallied in response.

ETF inflows. U.S. spot Solana ETFs logged a twelfth consecutive week of net inflows. BSOL was the primary beneficiary, crossing $1 billion in AUM and later surpassing $1.2 billion, with record single-day inflows of roughly $47 million to $60 million. Institutional accumulation through regulated products provided a structural bid.

Market dynamics. A wave of short liquidations, exceeding $20 million in a single session, added mechanical buying pressure, while a rebound in broader risk appetite and Bitcoin's recovery supported sentiment across the crypto market. On-chain activity, including leading decentralized exchange (DEX) volume and stablecoin supply above $15 billion, underpinned the fundamental narrative. From what I see, these elements together created a strong tailwind.

Quarterly Performance and Broader Drivers

The three-month picture reflects a broader trend reversal. Solana ended a prolonged multi-month downtrend, posting its first positive monthly candle in roughly ten months as it rebounded from levels near $60 in July. Renewed demand stemmed from both speculative and institutional channels.

Staking played a central role. With roughly 70% of the network's supply staked and staking rewards near 6.4% annually, yield-seeking capital gravitated toward products like BSOL that package price exposure with staking income. At the same time, growing tokenization activity—spanning tokenized treasuries, private credit, and funds from major asset managers—created a new institutional demand channel for Solana as a settlement layer.

Fund flows reinforced the move. Spot Solana ETFs accumulated more than $1.4 billion in net inflows over the quarter, with BSOL capturing the majority. This persistent, product-driven demand distinguished the quarter's advance from a purely speculative rally and helped sustain the trend across multiple weeks.

What to Watch Going Forward

Several factors are likely to shape BSOL's trajectory in the months ahead. The scheduled mainnet activation of Solana's Alpenglow upgrade represents a key technical milestone; successful implementation could reinforce the network's scalability narrative, while any delays or disruptions could weigh on sentiment.

ETF flows remain a critical barometer. The sustainability of record inflows will depend on continued institutional adoption and the appeal of staking yields relative to prevailing interest rates. Monetary policy is a relevant input, as higher rates can pressure risk assets broadly and alter the relative attractiveness of yield-bearing crypto products.

Regulatory clarity and the expansion of tokenized real-world assets (RWA) on Solana are additional themes to monitor, given their potential to deepen institutional participation. At the same time, the fund's single-asset concentration means investors should expect volatility, with sharp drawdowns possible even within broader uptrends. Bitcoin's direction, overall crypto market liquidity, and the pace of staking participation will also remain important context for the fund's near-term behavior. I'm watching this closely as the setup evolves.

Using Tickeron’s AI Tools in My Research

In my own workflow, I frequently rely on Tickeron’s AI-powered platforms to scan for patterns and compare opportunities across sectors. The AI Screener stands out for its ability to filter securities by technical indicators, fundamentals, volatility, and AI-generated signals, which helps me quickly surface candidates in fast-moving areas like digital assets without manual effort. It has become a regular part of how I evaluate products such as BSOL alongside peers.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BSOL

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


Momentum Indicator for BSOL turns positive, indicating new upward trend

BSOL saw its Momentum Indicator move above the 0 level on September 17, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator turned positive. In 14 of the 15 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for BSOL just turned positive on September 21, 2026. Looking at past instances where BSOL's MACD turned positive, the stock continued to rise in 5 of 5 cases over the following month. The odds of a continued upward trend are 90%.

Following a +17.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where BSOL advanced for three days, in 34 of 40 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

The Aroon Indicator entered an Uptrend today. In 12 of 17 cases where BSOL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.

Bearish Trend Analysis

The 10-day RSI Indicator for BSOL moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 1 similar instances where the indicator moved out of overbought territory. In 1 of the 1 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BSOL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

BSOL broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Industry description

The investment seeks to provide exposure to the value of Solana held by the Trust, less the expenses of the Trust’s operations and other liabilities and to derive additional Solana through staking. In seeking to achieve its primary investment objective, the Trust will hold Solana and establish its net asset value (“NAV”) by reference to the CME CF Solana – Dollar Reference Rate – New York Variant (“Pricing Benchmark”). The Trust is sponsored and managed by Bitwise Investment Advisers, LLC (the “Sponsor”).
View a ticker or compare two or three
BSOL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Digitalcurrency

Category
Digital Assets
Address
United States
Phone
N/A
Web
N/A
Interact to see
Advertisement
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.